Exchange Agreement, Dated August 19, 2026, Between Profusa, Inc. and Ascent Partners Fund Llc
Profusa, Inc.
EXCHANGE AGREEMENT
This Exchange Agreement (this “Agreement”) is dated as of August 19, 2026, between Profusa, Inc., a Delaware corporation (the “Company”) and Ascent Partners Fund LLC, a Delaware limited liability company (including its successors and assigns, the “Holder”).
WHEREAS, in connection with the transactions contemplated by that certain Option Agreement, dated as of July 31, 2026, by and among the Company, CentralLarkfieldKarin NA LLC, Venkata Boyapalli, a privately held trust, G3 Vision Labs Inc., Med Screen Laboratories Inc., Dominion Diagnostics LLC and Acutis Diagnostics Inc. (as amended, the “Option Agreement”), the Company is restructuring certain of its outstanding indebtedness, and, subject to the terms and conditions set forth in this Agreement, the Company and the Holder desire to exchange the Existing Notes (as defined below) for shares of Preferred Stock (as defined below).
NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Company and the Holder agrees as follows:
ARTICLE I.
DEFINITIONS
1.1 Definitions. In addition to the terms defined elsewhere in this Agreement: (a) capitalized terms that are not otherwise defined herein have the meanings given to such terms in the Certificate of Designation (as defined herein), and (b) the following terms have the meanings set forth in this Section 1.1:
“Acquiring Person” shall have the meaning ascribed to such term in Section 4.7.
…